AbCellera Biologics (STU:8QQ) Total Equity : €1,008.56 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is AbCellera Biologics Total Equity?

AbCellera Biologics's total equity for the quarter that ended in Dec. 2024 was €1,008.56 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AbCellera Biologics Total Equity Historical Data

The historical data trend for AbCellera Biologics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbCellera Biologics Total Equity Chart

AbCellera Biologics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

682.68

907.77

1,164.21

1,056.68

1,008.56

AbCellera Biologics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Equity	Get a 7-Day Free Trial															1,056.68	1,039.52	1,032.09	971.36	1,008.56

AbCellera Biologics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AbCellera Biologics's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	1299.328	-	290.768
	=	1,008.56

AbCellera Biologics's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2024 )	-	Total Liabilities(Q: Dec. 2024 )
	=	1299.328	-	290.768
	=	1,008.56

AbCellera Biologics Total Equity Related Terms

Thank you for viewing the detailed overview of AbCellera Biologics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AbCellera Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AbCellera Biologics Inc (STU:8QQ) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

ABCL:USA 8QQ:Germany

Address

150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6

Website

https://www.abcellera.com

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

AbCellera Biologics Headlines

No Headlines